title: Efficacy and safety of chaperonin 10 in patients with moderate to severe plaque psoriasis: evidence of utility beyond a single indication.
authors.forename: Bronwyn
authors.initials: B
authors.lastname: Williams
authors.forename: Daina
authors.initials: D
authors.lastname: Vanags
authors.forename: Stephen
authors.initials: S
authors.lastname: Hall
authors.forename: Chris
authors.initials: C
authors.lastname: McCormack
authors.forename: Peter
authors.initials: P
authors.lastname: Foley
authors.forename: Julissa
authors.initials: J
authors.lastname: Weiss
authors.forename: Barbara
authors.initials: B
authors.lastname: Johnson
authors.forename: Eicke
authors.initials: E
authors.lastname: Latz
authors.forename: Dennis
authors.initials: D
authors.lastname: Feeney
mesh_terms: D000328:Adult; D000368:Aged; D018835:Chaperonin 10 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018835:Chaperonin 10